Phlorotannins from Ecklonia cava Regulate Dual Signaling Pathways, IL-17RA/Act1 and ERK1/2, to Suppress Ovarian Cancer Progression and Tumor-Associated Macrophage Activation
Open Access
- 24 December 2025
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 24 (1) , 12
Abstract
Background: Marine-derived secondary metabolites such as phlorotannins from the edible brown alga Ecklonia cava exhibit diverse bioactivities. However, their mechanisms in inflammation-associated cancer remain insufficiently understood. Methods: This study explored the anticancer potential of three major phlorotannins (dieckol, 7-phloroeckol, and 8,8′-bieckol) through network pharmacology, molecular docking, molecular dynamics simulations, and in vitro validation in SKOV3 ovarian cancer cells and tumor-associated macrophages (TAMs). Results: Computational analyses revealed stable binding of phlorotannins to IL-17RA, with 7-phloroeckol and 8,8′-bieckol preferentially engaging loop-proximal regions of the receptor, while dieckol interacted with spatially distinct residues. In SKOV3 ovarian cancer cells, phlorotannins suppressed migration and invasion by approximately 40 to 60%, accompanied by reduced MMP expression linked to IL-17RA–Act1 signaling attenuation and by increased TIMP1 expression in association with transient ERK1/2 activation. In TAMs, phlorotannins attenuated pro-tumorigenic cytokine production and polarization marker expression, indicating suppression of tumor-supportive immune activity. Conclusions: Collectively, these findings demonstrate that E. cava-derived phlorotannins exert anti-metastatic effects through dual regulation of IL-17RA/Act1 and ERK1/2 signaling pathways, offering mechanistic insight into their therapeutic potential against inflammation-driven malignancies.Keywords
Funding Information
- National Research Foundation of Korea (RS-2020-NR055141)
- Korea Health Industry Development Institute (RS-2023-KH139660)
This publication has 84 references indexed in Scilit:
- Plasma proteomes and metabolism with genome-wide association data for causal effect identification in ovarian cancerDiscover Oncology, 2025
- Down-regulation of DPP4 by TGFβ1/miR29a-3p inhibited proliferation and promoted migration of ovarian cancer cellsDiscover Oncology, 2023
- Role of the TLR4-androgen receptor axis and genistein in taxol-resistant ovarian cancer cellsBiochemical Pharmacology, 2020
- IL-17A promotes fatty acid uptake through the IL-17A/IL-17RA/p-STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironmentCancer Immunology, Immunotherapy, 2019
- Magnolin targeting of ERK1/2 inhibits cell proliferation and colony growth by induction of cellular senescence in ovarian cancer cellsMolecular Carcinogenesis, 2018
- High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cellsClinical and Translational Oncology, 2017
- New insights in the pathophysiology of ovarian cancer and implications for screening and preventionAmerican Journal of Obstetrics and Gynecology, 2015
- PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125bBiochemical and Biophysical Research Communications, 2015
- Dieckol, isolated from the edible brown algae Ecklonia cava, induces apoptosis of ovarian cancer cells and inhibits tumor xenograft growthJournal of Cancer Research and Clinical Oncology, 2014
- Phlorotannins from Ecklonia cava (Phaeophyceae): Biological activities and potential health benefitsBioFactors, 2010